1. Tang, Ce, Sun, Haiyang, Kadoki, Motohiko, Trombetta, Sergio, Iwakura, Yoichiro. 2023. Blocking Dectin-1 prevents colorectal tumorigenesis by suppressing prostaglandin E2 production in myeloid-derived suppressor cells and enhancing IL-22 binding protein expression. In Nature communications, 14, 1493. doi:10.1038/s41467-023-37229-x. https://pubmed.ncbi.nlm.nih.gov/36932082/
2. Fachi, José L, Di Luccia, Blanda, Gilfillan, Susan, Gordon, Jeffrey I, Colonna, Marco. 2024. Deficiency of IL-22-binding protein enhances the ability of the gut microbiota to protect against enteric pathogens. In Proceedings of the National Academy of Sciences of the United States of America, 121, e2321836121. doi:10.1073/pnas.2321836121. https://pubmed.ncbi.nlm.nih.gov/38687788/
3. Laaksonen, H, Guerreiro-Cacais, A O, Adzemovic, M Z, Jagodic, M, Olsson, T. 2014. The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation. In Genes and immunity, 15, 457-65. doi:10.1038/gene.2014.36. https://pubmed.ncbi.nlm.nih.gov/25008863/
4. de Vor, Inge C, van der Meulen, Pomme M, Bekker, Vincent, van de Vosse, Esther, Bredius, Robbert G M. 2016. Deletion of the entire interferon-γ receptor 1 gene causing complete deficiency in three related patients. In Journal of clinical immunology, 36, 195-203. doi:10.1007/s10875-016-0244-y. https://pubmed.ncbi.nlm.nih.gov/26931784/
5. Lill, Christina M, Schilling, Marcel, Ansaloni, Sara, Zipp, Frauke, Bertram, Lars. 2014. Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosis. In Neurogenetics, 15, 129-34. doi:10.1007/s10048-014-0396-y. https://pubmed.ncbi.nlm.nih.gov/24638856/
6. Gómez-Fernández, Paloma, Urtasun, Andoni, Paton, Adrienne W, Alloza, Iraide, Vandenbroeck, Koen. 2018. Long Interleukin-22 Binding Protein Isoform-1 Is an Intracellular Activator of the Unfolded Protein Response. In Frontiers in immunology, 9, 2934. doi:10.3389/fimmu.2018.02934. https://pubmed.ncbi.nlm.nih.gov/30619294/